STERIS Management

Management criteria checks 3/4

STERIS' CEO is Dan Carestio, appointed in Jul 2021, has a tenure of 3.5 years. total yearly compensation is $9.55M, comprised of 10.8% salary and 89.2% bonuses, including company stock and options. directly owns 0.057% of the company’s shares, worth $12.88M. The average tenure of the management team and the board of directors is 4.5 years and 7.4 years respectively.

Key information

Dan Carestio

Chief executive officer

US$9.6m

Total compensation

CEO salary percentage10.8%
CEO tenure3yrs
CEO ownership0.06%
Management average tenure4.5yrs
Board average tenure7.4yrs

Recent management updates

Recent updates

When Should You Buy STERIS plc (NYSE:STE)?

Jul 04
When Should You Buy STERIS plc (NYSE:STE)?

Is STERIS (NYSE:STE) Using Too Much Debt?

Jun 13
Is STERIS (NYSE:STE) Using Too Much Debt?

Steris: Moving On, Losing Its Teeth

Apr 14

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

Mar 29
STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Mar 07
STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Steris: Strong Healthcare Products Growth Coupled With Weak AST Business

Feb 17

STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't

Feb 15
STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't

An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued

Dec 17
An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued

Should You Investigate STERIS plc (NYSE:STE) At US$203?

Nov 24
Should You Investigate STERIS plc (NYSE:STE) At US$203?

Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes

Nov 08

We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt

Nov 06
We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt

Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?

Sep 18
Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?

Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage

Sep 01

When Should You Buy STERIS plc (NYSE:STE)?

Aug 10
When Should You Buy STERIS plc (NYSE:STE)?

Steris: Continuing To Grow The Product Lineup

Jun 20

Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered

Feb 09

Steris declares $0.47 dividend

Feb 01

These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well

Feb 01
These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)

Dec 28
Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)

Steris declares $0.47 dividend

Nov 02

STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Nov 01
STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Steris: Non-GAAP Valuations Supportive Of Substantial Upside

Sep 04

STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47

Aug 18
STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47

STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47

Aug 04
STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47

Steris Non-GAAP EPS of $1.90 in-line, revenue of $1.2B misses by $20M

Aug 02

Is STERIS (NYSE:STE) A Risky Investment?

Jul 19
Is STERIS (NYSE:STE) A Risky Investment?

Steris: Deleveraging Key Undercurrent, Valuation A Concern

Jun 12

STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Apr 08
STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

CEO Compensation Analysis

How has Dan Carestio's remuneration changed compared to STERIS's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024US$10mUS$1m

US$551m

Dec 31 2023n/an/a

US$567m

Sep 30 2023n/an/a

US$550m

Jun 30 2023n/an/a

US$119m

Mar 31 2023US$8mUS$970k

US$557m

Dec 31 2022n/an/a

-US$28m

Sep 30 2022n/an/a

-US$8m

Jun 30 2022n/an/a

US$377m

Mar 31 2022US$6mUS$767k

US$285m

Dec 31 2021n/an/a

US$279m

Sep 30 2021n/an/a

US$250m

Jun 30 2021n/an/a

US$286m

Mar 31 2021US$3mUS$542k

US$397m

Dec 31 2020n/an/a

US$433m

Sep 30 2020n/an/a

US$424m

Jun 30 2020n/an/a

US$413m

Mar 31 2020US$2mUS$522k

US$408m

Dec 31 2019n/an/a

US$393m

Sep 30 2019n/an/a

US$336m

Jun 30 2019n/an/a

US$319m

Mar 31 2019US$2mUS$482k

US$304m

Dec 31 2018n/an/a

US$269m

Sep 30 2018n/an/a

US$316m

Jun 30 2018n/an/a

US$303m

Mar 31 2018US$1mUS$379k

US$291m

Compensation vs Market: Dan's total compensation ($USD9.55M) is about average for companies of similar size in the US market ($USD13.17M).

Compensation vs Earnings: Dan's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


CEO

Dan Carestio (51 yo)

3yrs

Tenure

US$9,550,776

Compensation

Mr. Daniel A. Carestio, also known as Dan, serves as the Chief Executive Officer & President at STERIS plc since July 29, 2021. He had been Senior Vice President and Chief Operating Officer at STERIS plc s...


Leadership Team

NamePositionTenureCompensationOwnership
Daniel Carestio
President3yrsUS$9.55m0.057%
$ 12.9m
Michael Tokich
Senior VP & CFO16.3yrsUS$3.24m0.047%
$ 10.6m
John Zangerle
Senior VP11yrsUS$2.63m0.034%
$ 7.6m
Mary Fraser
SVP & Chief Human Resources Officer4yrsUS$1.85m0.011%
$ 2.5m
Cary Majors
Senior VP & President of Healthcare4.9yrsUS$2.15m0.013%
$ 3.0m
Karen Burton
VP & Chief Accounting Officer7.5yrsno data0.0044%
$ 1.0m
Julie Winter
Vice President of Investor Relations & Corporate Communicationsno datano datano data
Julia Madsen
Senior VP & GM of Life Sciences4yrsno data0.0098%
$ 2.2m
Andrew Xilas
Senior VP & GM of Dental3.1yrsUS$1.92m0.0064%
$ 1.5m
Kenneth Kohler
Senior VP & GM of ASTno datano data0.0035%
$ 795.8k
Renato Tamaro
VP & Corporate Treasurer6.9yrsno data0.0070%
$ 1.6m
Walter Rosebrough
CEO Emeritus & Senior Advisor3yrsUS$1.16mno data

4.5yrs

Average Tenure

56yo

Average Age

Experienced Management: STE's management team is considered experienced (4.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Daniel Carestio
President3.5yrsUS$9.55m0.057%
$ 12.9m
Richard Breeden
Independent Director16.3yrsUS$353.94k0.033%
$ 7.4m
Mohsen Sohi
Independent Chairman of the Board19yrsUS$503.73k0.023%
$ 5.1m
Jacqueline Kosecoff
Independent Director20.8yrsUS$348.93k0.027%
$ 6.1m
Cynthia Feldmann
Independent Director19.3yrsUS$349.84k0.0095%
$ 2.1m
Richard Steeves
Independent Director8.7yrsUS$349.96k0%
$ 0
Paul Martin
Independent Director3.2yrsUS$342.28kno data
Nirav Shah
Independent Director6.2yrsUS$336.34k0.00030%
$ 67.8k
Christopher Holland
Independent Director4yrsUS$342.34k0.000070%
$ 15.8k
Esther Alegria
Independent Director1.2yrsUS$408.96kno data

7.4yrs

Average Tenure

65yo

Average Age

Experienced Board: STE's board of directors are considered experienced (7.4 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.